表紙
市場調查報告書

胰管腺癌症:全球臨床實驗分析

Pancreatic Ductal Adenocarcinoma Global Clinical Trials Review, H2, 2019

出版商 GlobalData 商品編碼 925163
出版日期 內容資訊 英文
訂單完成後即時交付
價格
胰管腺癌症:全球臨床實驗分析 Pancreatic Ductal Adenocarcinoma Global Clinical Trials Review, H2, 2019
出版日期: 2019年12月15日內容資訊: 英文
簡介

本報告提供全球胰管腺癌症治療藥臨床實驗調查分析,提供各地區,各國,不同階段,各臨床實驗狀況,各評估項目狀況,各贊助商類型臨床實驗相關最新資訊之系統性資訊。

目錄

調查指導

調查對象

臨床實驗數量:各地區

  • 臨床實驗數量和平均實驗人數:各國
    • 亞太地區主要5國臨床實驗數量
    • 歐洲主要5國臨床實驗數量
    • 北美主要國家臨床實驗數量
    • 中東·非洲的主要國家臨床實驗數量
    • 中南美的主要國家臨床實驗數量

臨床實驗數量:G7各國 - 腫瘤臨床實驗上胰管腺癌症的比例

臨床實驗數量:G7各國各期

G7各國的臨床實驗數量:各檢測狀況

臨床實驗數量:E7各國 - 腫瘤臨床實驗上胰管腺癌症的比例

臨床實驗數量:E7各國各期

E7各國的臨床實驗數量:各檢測狀況

臨床實驗數量:不同階段

  • 進行中的臨床實驗:不同階段

臨床實驗數量:各檢測狀況

臨床實驗數量:各評估項目狀況

一定期間所採用的實驗對象

臨床實驗數量:各贊助商類型

有力的贊助商

  • 胰管腺癌症治療藥參與臨床實驗的主要企業

有力的藥物

胰管腺癌症治療藥臨床實驗相關最新消息

臨床實驗簡介概要

附錄

目錄
Product Code: GDHC6016CTIDB

GlobalData's clinical trial report, "Pancreatic Ductal Adenocarcinoma Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Pancreatic Ductal Adenocarcinoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Ductal Adenocarcinoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Pancreatic Ductal Adenocarcinoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pancreatic Ductal Adenocarcinoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Pancreatic Ductal Adenocarcinoma
  • Nov 06, 2019: Oncolytics Biotech announces publication of positive REO 024 study results for Pelareorep in combination with Keytruda in patients with Advanced Pancreatic Adenocarcinoma
  • Nov 05, 2019: Gritstone Oncology announces data on novel shared tumor-specific neoantigens identified by its EDGE platform and contained within its SLATE Immunotherapy
  • Oct 15, 2019: Oncolytics Biotech presents clinical data highlighting the effectiveness of intravenous delivery to and replication of Pelareorep in tumors
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Source

List of Tables

  • Pancreatic Ductal Adenocarcinoma Therapeutics, Global, Clinical Trials by Region, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2019*
  • Proportion of Pancreatic Ductal Adenocarcinoma to Oncology Clinical Trials, G7 Countries (%), 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Pancreatic Ductal Adenocarcinoma to Oncology Clinical Trials, E7 Countries (%), 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Pancreatic Ductal Adenocarcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures

  • Pancreatic Ductal Adenocarcinoma Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Pancreatic Ductal Adenocarcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Pancreatic Ductal Adenocarcin